Inogen, Inc (INGN)
Healthcare • Medical Devices • $7.04 • MCap: 165,864,608
https://www.provider.inogen.com • Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.
ET
| Score | Price | 52 Week & Averages | Relative Strength | Risk | |||||
|---|---|---|---|---|---|---|---|---|---|
| Total | 43 | Current | $7.04 | 52W High | $8.95 -21.34% | Relative Strength | 0.05 | Beta | 1.50 |
| Business Quality | 7 | Weekly | $6.30 11.83% | 52W Low | $5.09 38.31% | 3M | 0.14 | Short % | 0.06 |
| Financial Strength | 10 | Monthly | $5.23 34.61% | Above 50DMA | $5.66 24.28% | 6M | 0.01 | Risk Score | 5 |
| Growth Outlook | 1 | Quarterly | $6.15 14.47% | Above 200DMA | $6.21 13.30% | 9M | 0.13 | ||
| Momentum | 5 | Yearly | $8.66 -18.71% | 12M | -0.20 | ||||
| Valuation | Financial Strength | Growth/Profitability | |||
|---|---|---|---|---|---|
| Trailing P/E | N/A | Cash | 106M | Revenue Growth | 0.03% |
| Forward P/E | -39.06 | Debt | 16M | Earnings Growth | N/A |
| PEG Ratio | N/A | Debt/Equity | 9.03 | Qtr Earnings Growth | N/A |
| Price/Sales | 0.47 | Current Ratio | 2.74 | Gross Margin | 0.45% |
| Price/Book | 0.96 | Quick Ratio | 2.14 | Operating Margin | -0.05% |
| EV/Revenue | 0.22 | Operating CF | -3M | Profit Margin | -0.07% |
| EV/EBITDA | -9.41 | Free CF | -2M | EBITDA Margin | -0.02% |
| Ent Value | 76M | Return on Assets | -0.06% | ||
| Return on Equity | -0.13% | ||||
| Technical | Volume & Bollinger Bands | Analyst | |||
|---|---|---|---|---|---|
| RSI | 75.16 | Volume | 0.19M | Rating | none |
| Previous RSI | 69.84 | Avg Volume 20D | 0.35M | Target Mean | $12.00 |
| RSI Trend | Up | Relative Volume | 1.40 | Target High | $12.00 |
| MACD | 0.32 | Lower Band | 5.10 | Target Low | $12.00 |
| MACD Signal | 0.23 | Middle Band | 6.07 | Target Median | $12.00 |
| Histogram | 0.09 | Upper Band | 7.04 | Analysts | 2 |
| Previous Histogram | 0.08 | Bandwidth | 31.870 | Upside | 92.00% |
| Histogram Trend | Increasing | %B | 1.00 | ||
